Regenerative firm Creative Medical launches cardio-focused AngioStem biz

Regenerative biotech company Creative Medical Health said today it is launching a subsidiary biz, AngioStem, to commercialize its cardiovascular assets. Assets on hand for the newly launched company include a therapy that uses autologous and allogeneic adult stem cells in combination with modulation of oxidative stress to treat heart failure in patients with cardiovascular disease, Creative Medical Health said. “At Creative Medical Health, our mission is to identify promising technologies, add value by strengthening the science and intellectual property surrounding the technologies, and subsequently spin off new companies with specialized management teams. The development of a business strategy, the successful acquisition of independent funding to implement the strategy, and the recruitment of a management team to lead the strategy have positioned our cardiac stem cell technology to evolve from a promising technology into a functioning corporation,” Creative Medical Health CEO Timothy Warbington said in prepared remarks. The company’s initial cardiovascular disease treatment patent also includes in-treatment assessment of oxidative stress, which Creative Medical Health said allows doctors the ability to personalize the treatment protocols. “I look forward to working with the management team of AngioStem to bring stem cell technologies to patients who currently have no treatment options available. The promise of stem cell therapeutics offers the possib...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Cardiovascular Regenerative Medicine AngioStem Creative Medical Health Source Type: news